Utsugisawa K - Search Results

1

Zilucoplan: An Investigational Complement C5 Inhibitor for the Treatment of Acetylcholine Receptor Autoantibody-Positive Generalized Myasthenia Gravis.

Howard JF Jr, Vissing J, Gilhus NE, Leite MI, Utsugisawa K, Duda PW, Farzaneh-Far R, Murai H, Wiendl H. Howard JF Jr, et al. Among authors: utsugisawa k. Expert Opin Investig Drugs. 2021 May;30(5):483-493. doi: 10.1080/13543784.2021.1897567. Epub 2021 Apr 1. Expert Opin Investig Drugs. 2021. PMID: 33792453 Review.

2

[Plasmapheresis therapy of myasthenia gravis].

Sano M, Utsugisawa K, Tohgi H. Sano M, et al. Among authors: utsugisawa k. Nihon Rinsho. 1992 Jan;50 Suppl:337-44. Nihon Rinsho. 1992. PMID: 1578705 Japanese. No abstract available.

3

Effects of FK506 on myasthenia gravis patients with high interleukin-2 productivity in peripheral blood mononuclear cells.

Utsugisawa K, Nagane Y, Yonezawa H, Obara D, Kondoh R, Tohgi H. Utsugisawa K, et al. Muscle Nerve. 2003 Feb;27(2):245-8. doi: 10.1002/mus.10285. Muscle Nerve. 2003. PMID: 12548534 Clinical Trial.

4

Two-year treatment with cyclosporine microemulsion for responder myasthenia gravis patients.

Nagane Y, Suzuki S, Suzuki N, Utsugisawa K. Nagane Y, et al. Among authors: utsugisawa k. Eur Neurol. 2010;64(3):186-90. doi: 10.1159/000319172. Epub 2010 Aug 17. Eur Neurol. 2010. PMID: 20720424 Clinical Trial.

5

[Thymic abnormalities in patients with myasthenia gravis].

Utsugisawa K, Nagane Y. Utsugisawa K, et al. Brain Nerve. 2011 Jul;63(7):685-94. Brain Nerve. 2011. PMID: 21747138 Review. Japanese.

6

[Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids].

Utsugisawa K, Nagane Y, Suzuki S, Suzuki N. Utsugisawa K, et al. Rinsho Shinkeigaku. 2012;52(11):1047-50. doi: 10.5692/clinicalneurol.52.1047. Rinsho Shinkeigaku. 2012. PMID: 23196511 Japanese.

7

[Therapeutic strategies against myasthenia gravis].

Utsugisawa K, Nagane Y. Utsugisawa K, et al. Nihon Rinsho. 2013 May;71(5):881-6. Nihon Rinsho. 2013. PMID: 23777099 Review. Japanese.

8

Is surgical intervention safe and effective in the treatment of myasthenic blepharoptosis? A multicenter survey in Japan.

Shimizu Y, Suzuki S, Utsugisawa K, Imai T, Murai H, Nagane Y, Tsuda E, Nagasao T, Ogata H, Yazawa M, Suzuki N, Kishi K. Shimizu Y, et al. Among authors: utsugisawa k. Eur Neurol. 2014;71(5-6):259-61. doi: 10.1159/000356793. Epub 2014 Feb 5. Eur Neurol. 2014. PMID: 24503883 Free article. No abstract available.

9

Health-related quality-of-life and treatment targets in myasthenia gravis.

Utsugisawa K, Suzuki S, Nagane Y, Masuda M, Murai H, Imai T, Tsuda E, Konno S, Nakane S, Suzuki Y, Fujihara K, Suzuki N. Utsugisawa K, et al. Muscle Nerve. 2014 Oct;50(4):493-500. doi: 10.1002/mus.24213. Epub 2014 Aug 30. Muscle Nerve. 2014. PMID: 24536040

10

Quality of life in purely ocular myasthenia in Japan.

Suzuki S, Murai H, Imai T, Nagane Y, Masuda M, Tsuda E, Konno S, Oji S, Nakane S, Motomura M, Suzuki N, Utsugisawa K. Suzuki S, et al. Among authors: utsugisawa k. BMC Neurol. 2014 Jul 5;14:142. doi: 10.1186/1471-2377-14-142. BMC Neurol. 2014. PMID: 24996227 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters